Global Chemotherapy Drugs Market is projected to display a robust growth represented by a CAGR of 11.91% during 2018 - 2023

Wednesday, May 8, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 7, 2019 /PRNewswire/ -- Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Chemotherapy Drugs Market. The report analyzes the Chemotherapy Drugs Market, By Type of Drug (Antimetabolites,

Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others), By Route of Administration (Oral, Intravenous, Others). The chemotherapy drugs market has been analyzed By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, United Kingdom, Germany, China and India) for the historical period of 2013-2017 and the forecast period of 2018-2023. Read the full report: https://www.reportlinker.com/p05763293/?utm_source=PRN According to the report, "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China and India)", global market is projected to display a robust growth represented by a CAGR of 11.91% during 2018 – 2023. On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc. Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government's focus on medical infrastructural developments. The report titled "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China and India)" has covered and analyzed the potential of global chemotherapy drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global chemotherapy drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe. Scope of the Report Global Chemotherapy Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023 • Global Chemotherapy Drugs Market – Size, Growth, Forecast • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) • By Route of Administration (Oral, Intravenous, Others) Regional Markets – North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023) • Regional Chemotherapy Drugs Market – Size, Growth, Forecast • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) • By Route of Administration (Oral, Intravenous, Others) Country Analysis – U.S, Canada, United Kingdom, Germany, China and India (Actual Period: 2013-2017, Forecast Period: 2018-2023) • Chemotherapy Drugs Market – Size, Growth, Forecast • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) • By Route of Administration (Oral, Intravenous, Others) Other Report Highlights: • Market Dynamics – Drivers and Restraints • Market Trends • SWOT Analysis • Porter Five Force Analysis • Policy and Regulatory Landscape • Company Analysis – Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited. Customization of the Report The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.Read the full report: https://www.reportlinker.com/p05763293/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/global-chemotherapy-drugs-market-is-projected-to-display-a-robust-growth-represented-by-a-cagr-of-11-91-during-2018--2023--300845625.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store